113 related articles for article (PubMed ID: 7912879)
1. Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine.
Feet PO; Götestam KG
Acta Psychiatr Scand; 1994 Apr; 89(4):230-4. PubMed ID: 7912879
[TBL] [Abstract][Full Text] [Related]
2. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial.
Modigh K; Westberg P; Eriksson E
J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
[TBL] [Abstract][Full Text] [Related]
5. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.
Broocks A; Bandelow B; Pekrun G; George A; Meyer T; Bartmann U; Hillmer-Vogel U; Rüther E
Am J Psychiatry; 1998 May; 155(5):603-9. PubMed ID: 9585709
[TBL] [Abstract][Full Text] [Related]
6. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
[TBL] [Abstract][Full Text] [Related]
8. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
9. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
[TBL] [Abstract][Full Text] [Related]
10. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
Lepola UM; Wade AG; Leinonen EV; Koponen HJ; Frazer J; Sjödin I; Penttinen JT; Pedersen T; Lehto HJ
J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
[TBL] [Abstract][Full Text] [Related]
11. Reversible monoamine oxidase-A inhibitors in panic disorder.
Bakish D; Saxena BM; Bowen R; D'Souza J
Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
[TBL] [Abstract][Full Text] [Related]
12. The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.
Fahy TJ; O'Rourke D; Brophy J; Schazmann W; Sciascia S
J Affect Disord; 1992 May; 25(1):63-75. PubMed ID: 1624646
[TBL] [Abstract][Full Text] [Related]
13. Clomipramine treatment of panic disorder: pros and cons.
Papp LA; Schneier FR; Fyer AJ; Leibowitz MR; Gorman JM; Coplan JD; Campeas R; Fallon BA; Klein DF
J Clin Psychiatry; 1997 Oct; 58(10):423-5. PubMed ID: 9375591
[TBL] [Abstract][Full Text] [Related]
14. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
Lecrubier Y; Bakker A; Dunbar G; Judge R
Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
[TBL] [Abstract][Full Text] [Related]
15. Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?
Wiborg IM; Dahl AA
Arch Gen Psychiatry; 1996 Aug; 53(8):689-94. PubMed ID: 8694682
[TBL] [Abstract][Full Text] [Related]
16. A double blind study in out-patients with primary non-agitated depression treated with imipramine in combination with placebo, diazepam or dixyrazine.
Feet PO; Larsen S; Robak OH
Acta Psychiatr Scand; 1985 Oct; 72(4):334-40. PubMed ID: 3907277
[TBL] [Abstract][Full Text] [Related]
17. A dose-finding and discontinuation study of clomipramine in panic disorder.
Lotufo-Neto F; Bernik M; Ramos RT; Andrade L; Gorenstein C; Cordas T; Melo M; Gentil V
J Psychopharmacol; 2001 Mar; 15(1):13-7. PubMed ID: 11277602
[TBL] [Abstract][Full Text] [Related]
18. Memory performance in panic disorder patients after chronic use of clomipramine.
de Carvalho SC; Marcourakis T; Artes R; Gorenstein C
J Psychopharmacol; 2002 Sep; 16(3):220-6. PubMed ID: 12236628
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
[TBL] [Abstract][Full Text] [Related]
20. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
Mavissakalian MR; Perel JM
Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
